bar_chartAcumen Pharmaceuticals, Inc.
ABOS | Healthcare | Biotechnology
bar_chartPerformance
bar_chartPerformance(Quarter)
bar_chartCash Flow
bar_chartCash Flow(Quarter)
bar_chartInstitutional Holders
| Holder | % Out | Shares |
|---|---|---|
| RA Capital Management, L.P. | 24.14% | 9,770,773 |
| Sands Capital Ventures, LLC | 8.44% | 3,417,075 |
| Blackrock Inc. | 7.68% | 3,109,670 |
| Deep Track Capital, LP | 4.78% | 1,933,040 |
| Rock Springs Capital Management, LP | 3.88% | 1,571,918 |
| Laurion Capital Management, LP | 1.62% | 656,848 |
| Janus Henderson Group PLC | 1.55% | 627,263 |
| Franklin Resources, Inc. | 1.49% | 602,266 |
| Vanguard Group, Inc. (The) | 1.37% | 554,973 |
| Guardian Point Capital, LP | 1.24% | 500,000 |
bar_chartMutual Fund Holders
| Holder | % Out | Shares |
|---|---|---|
| Blackrock Funds-Health Sciences Opportunity Portfolio | 1.91% | 772,313 |
| Vanguard Total Stock Market Index Fund | 0.86% | 348,229 |
| iShares NASDAQ Biotechnology ETF | 0.69% | 280,147 |
| iShares Russell 2000 ETF | 0.55% | 223,408 |
| Franklin Strategic Series-Franklin Biotechnology Discove | 0.35% | 142,991 |
| Vanguard Extended Market Index Fund | 0.3% | 120,938 |
| Fidelity Small Cap Index Fund | 0.16% | 65,623 |
| iShares Russell 2000 Growth ETF | 0.13% | 51,272 |
| Fidelity Extended Market Index Fund | 0.11% | 44,698 |
| iShares Russell 2000 Value ETF | 0.1% | 38,897 |